Review paper:
Kim PS; Djazayeri S; Zeineldin R. Novel nanotechnology
approaches to diagnosis and therapy of ovarian cancer.
Gynecologic Oncology.
2011, 120:393-403.
Dr. Paul Kim
PharmD
Class of 2012
Dr. Shabdis Djazayeri
PharmD
Class of 2012
Amal Abdulghani
Graduate Student
Musaed Alkholief
Graduate Student
Poster:
First Annual NanoWorcester
Poster:
AlKholief M, Abdulghani A, Zeineldin R. Intracellular
fate of carbon nanotubes targeting specific receptors
on ovarian cancer cells. Nano in Cancer – American
Association of Cancer Research (AACR) special
conference. Jan 12-15,
2011. Miami, Fl.
Poster:
First Annual NanoWorcester
Symposium, MCPHS, Feb
2011
Review paper:
Cowden Dahl K, Chan TW, Balkhi B, Zeineldin R. focus on
Trabectedin. Clinical Medicine Reviews in Oncology.
2011,
3:93-105.
Teresa
Bander
Dr. Joseph Youkhanna
PharmD
Class of 2011
Dr. Joan Syoufjy
PharmD
Class of 2011
My students' publications / presentations
Poster:
Amal Abdulghani, Nhu Nguyen, Abdullah Assiri, Sarah Liu,
Reema Zeineldin. A novel ozone-sensitive nanotechnology
platform for treatment of ovarian cancer. Gordon Conference
on Cancer Nanotechnology. Colby College, Waterville, ME.
July 17-21,
2011.
Amal Abdulghani
Graduate Student
Dr. Nhu Nguyen
PharmD
Class of 2013
Dr. Abdullah Assiri
PharmD
Class of 2013
Poster:
Jessica Rogers, Dennis Benko, Ahmed Ashour, Reema
Zeineldin. Inhibition of Rac1 and CDC42 disrupts formation of
spheroids in ovarian cancers. 2011 ASHP Midyear Clinical
Meeting. New Orleans, Louisiana, December 4-8,
2011.
Dr. Dennis Benko
PharmD
Class of 2012
Dr. Jessica Rogers
PharmD
Class of 2012
Poster:
Kirill Goncharov, Reema Zeineldin.
Sensitizing resistant ovarian cancer cells to
chemotherapy through inhibition of small
GTPases. The American Association for
Cancer Research. Chicago, IL. April 1-4,
2012.
Dr. Kirill Goncharov
PharmD
Class of 2012
Poster:
Amal Abdulghani*, Reema Zeineldin. Employing the
inflammatory environment for drug release from
supported lipid bilayers in ovarian cancer. Second
Annual NanoWorcester Symposium. Worcester
Polytechnic Institute, Worcester, MA. March 17,
2012.
Review paper:
Youkhanna J, Syoufjy J, Rhorer M, Oledeinde O, Zeineldin R. Towards
nanotechnology-based solutions for a particular disease. Invited review to
Nanotechnology Reviews.
2013.
Dr. Oyebola Oledeinde
& Dr. Marry Rhorer,
PharmD
Class of 2013
Amal Abdulghani tied for 1st Place Prize for her poster in the Third Annual NanoWorcester Symposium held at Clark University on September 28,
2013. Her poster title: Employing the Inflammatory Environment for Drug Release from Lipid Particles in Ovarian Cancer. Amal Abdulghani, Reema
Zeineldin.
Amal Abdulghani
(MS in Pharmaceutics 2014)
Amal Abdulghani
(MS in Pharmaceutics 2014)
2nd Annual School of Pharmacy-Worcester/Manchester Research Day, MCPHS,
Worcester, MA. April 11, 2013:
  • Oyebola Oladeinde, Mary Rhorer, Reema Zeineldin. Viability of adherent and
    multicellular aggregates (MCAs) of ovarian cancer cells when treated with
    cisplatin.
  • Irene Zaitouna, Reema Zeineldin. Distance education: Does it make a difference?
  • Lola Adebukunola Adenuga, Reema Zeineldin. Avoiding inappropriate tablet
    splitting.
  • Ramin Amini, Josephine Dinh, Reema Zeineldin. The effects of counseling on
    patients’ adherence to medication.
  • Mohamed Sayed, Hui En Huang, Reema Zeineldin. The Role of Rac1 in ovarian
    cancer.
  • Amy Beshai, Christian Bialk, Reema Zeineldin. Making of a pharmacy dean: The
    leader of tomorrow.
  • Aleksandra Ferdman, Reema Zeineldin. Role of the pharmacist in the time of
    drug shortages: Compounding as a coping strategy.
  • Jay Xu, Reema Zeineldin. Does crushing of time-release pantoprazole affect its
    bioavailability?
  • Hui En Huang, John Sekab, Raissa Noubissie, Thu Vo, Reema Zeineldin.  
    Evaluating cytotoxicity of Rac1 inhibitor on ovarian cancer cells.
  • Meg Crighton, Toan La, Allen Yu, Reema Zeineldin. Detecting generation of
    reactive oxygen species by activated macrophages.
2nd Annual School of Pharmacy-Worcester/Manchester Research Day,
MCPHS University, Worcester, MA. April 11, 2013:
1st Annual School of Pharmacy-Worcester/Manchester Research Day,
MCPHS University, Worcester, MA. April 6, 2012:
  • Annmae C. Javier, Reema Zeineldin. The impact of service learning
    projects of healthcare professionals on the adolescent population.
  • Cherice Petit Cuthbert, Reema Zeineldin. Career assessments:
    matching PharmD students to careers..
  • Ali Chehab, Mohamed Sayed, Reema Zeineldin. Effects of small Rho-
    GTPase inhibitors on ovarian cancer migration and aggregation.
  • Nirmit Patel*, Reema Zeineldin. Stability of clopidogrel (PLAVIX®) is an
    extemporaneously compounded oral suspension.
  • Darbi Downey, Reema Zeineldin. How well are sterility guidelines
    adhered to and enforced in pharmacy compounding?
  • Priyanka Khanna, Reema Zeineldin. Expert’s perceptions of the
    pharmacist’s role in veterinary medicine.
3rd Annual School of Pharmacy-Worcester/Manchester Research Day, MCPHS University, Worcester, MA. April 10,
2014:
  • Mini Abraham,Thamer Alqurashi, Patricia Follet, Ashley Lee, Sarah Mian, Daisy Powers, Giuseppe Troia, Reema
    Zeineldin. Determining the effect of Rac‐1 inhibition on the expression of Claudin‐4 in ovarian cancer.
  • Hui En Huang, Reema Zeineldin. Rac1 inhibitor may improve ovarian cancer sensitivity to cisplatin.
  • Meg Crighton, Rich Albano, Allen Yu, Reema Zeineldin. Evaluation of cell proliferation of ovarian cancer cells
    after inhibiting Rac1.
Amal Abdulghani, Reema Zeineldin. Employing the inflammatory environment for drug release from lipid carriers. Annual
Meeting for the American Association of Pharmaceutical Scientists-North East Regional Discussion Group
(AAPS-NERDG). Rocky Hill, CT. April 19, 2013.
Mohamed Sayed, Hui En Huang, Mary Rhorer, Oyebola Oladeinde, Reema Zeineldin. Role of Rac1 in ovarian cancer.
Annual Meeting for the American Association of Pharmaceutical Scientists-North East Regional Discussion Group
(AAPS-NERDG). Rocky Hill, CT. April 19, 2013.
Amal Abdulghani, Reema Zeineldin. Developing a biosensor for reactive oxygen species. Gordon Conference on Bioanalytical Sensors. Salve Regina University,
Newport, RI. June 22-27, 2014.

Hui En Huang, Reema Zeineldin. Rac1 inhibitor improves ovarian cancer sensitivity to cisplatin. Submitted to 2013 American Society of Health-Systems Pharmacists
(ASHP) Midyear Clinical Meeting. Orlando, FL. December 8-12, 2013.

Amal Abdulghani, Reema Zeineldin. Releasing content of lipid drug delivery vehicles by immune-related molecules. Second Cancer Nanotechnology Gordon Research
Conference. Mount Snow Resort, West Dover, VT. July 14-19, 2013.
Hui En
Amal
Reema Zeineldin, Ph.D.
John Saulle, Jennifer Ridge, Lacey Cardillo, Annie Piché, Hart Lidov, Antonio Perez-Atayde, Harry Kozakewich, Sandra Alexandrescu. Mentors: Reema Zeineldin and Annie Piché. Tuberous Sclerosis – from Histology,
to Genes, to Therapy. Capstone Presentations for Senior Students. Mount Ida College, Newton, MA. May 3, 2016